SIRT5 and Sepsis: Targeting this pathway, for example, by enhancing SIRT5 activity to eliminate malonyl-CoA decarboxylase or by supplying malonyl-CoA decarboxylase to consume malonyl-CoA, could be a therapeutic strategy to protect the heart (and possibly other organs) in sepsis.